| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00004583-200008000-00009 |
| P698 | PubMed publication ID | 10939226 |
| P50 | author | Helen L Egger | Q42574792 |
| P2093 | author name string | Angold A | |
| Costello EJ | |||
| Erkanli A | |||
| P433 | issue | 8 | |
| P304 | page(s) | 975-84; discussion 984-94 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Journal of the American Academy of Child and Adolescent Psychiatry | Q6296081 |
| P1476 | title | Stimulant treatment for children: a community perspective | |
| P478 | volume | 39 |
| Q51031145 | A Controlled Trial of Working Memory Training for Children and Adolescents with ADHD |
| Q37696674 | A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication naive children with ADHD |
| Q36071173 | A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. |
| Q51239813 | ADHD Medication Trends in Turkey: 2009-2013. |
| Q33875428 | Adolescent outcomes of childhood attention-deficit/hyperactivity disorder in a diverse community sample |
| Q38353942 | Annual research review: The (epi)genetics of neurodevelopmental disorders in the era of whole-genome sequencing--unveiling the dark matter. |
| Q37852400 | Are Maternal Genitourinary Infection and Pre-Eclampsia Associated With ADHD in School-Aged Children? |
| Q36980430 | Assessing the diagnostic accuracy of the identification of hyperkinetic disorders following the introduction of government guidelines in England |
| Q46027856 | Association Between Perinatal Hypoxic-Ischemic Conditions and Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis. |
| Q22252309 | Attention Deficit Hyperactivity Disorder in Preschool Children |
| Q22251226 | Attention Deficit/Hyperactivity Disorder: A Review and Update |
| Q36253053 | Attention deficit disorder and stimulant use: an epidemic of modernity |
| Q61478500 | Attention deficit hyperactivity disorder |
| Q57400259 | Attention-deficit hyperactivity disorder |
| Q34223331 | Attention-deficit hyperactivity disorder. |
| Q35085285 | Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study |
| Q35559397 | Attention-deficit/hyperactivity disorder in children and adolescents: interventions for a complex costly clinical conundrum |
| Q37624713 | Attention-deficit/hyperactivity disorder severity, diagnosis, & later academic achievement in a national sample |
| Q73404034 | Attention‐deficit hyperactivity disorder in a life perspective |
| Q40592237 | Barriers to detection, help-seeking, and service use for children with ADHD symptoms |
| Q37127434 | Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults |
| Q38422344 | Changes in use of psychostimulant medication for ADHD in South Australia (1990-2006). |
| Q35573598 | Childhood behavioral and emotional disorders |
| Q30957276 | Children and adolescents with hyperkinetic disorder. Frequency of the claims diagnosis in primary care based on the data of a regional Statutory Health Insurance Sample--Versichertenstichprobe AOK Hessen/KV Hessen (1998-2001) |
| Q45212723 | Children's persistence with methylphenidate therapy: a population-based study |
| Q34313538 | Chronic D-amphetamine administered from childhood to adulthood dose-dependently increases the survival of new neurons in the hippocampus of male C57BL/6J mice |
| Q36897151 | Drug and non-drug treatments of children with ADHD and tic disorders |
| Q35964370 | Drug therapy of attention deficit hyperactivity disorder: current trends |
| Q37146492 | Early postnatal exposure to methylphenidate alters stress reactivity and increases hippocampal ectopic granule cells in adult rats |
| Q35676640 | Economic implications of attention-deficit hyperactivity disorder for healthcare systems |
| Q28479049 | Environmental enrichment preceding early adulthood methylphenidate treatment leads to long term increase of corticosterone and testosterone in the rat |
| Q57399827 | Epidemiology of Attention Deficit Hyperactivity Disorder |
| Q44400871 | Estimated prevalence of attention-deficit/ hyperactivity disorder symptoms among college freshmen: gender, race, and rater effects |
| Q36914817 | Evaluating the evidence for and against the overdiagnosis of ADHD. |
| Q21202070 | Facts, values, and attention-deficit hyperactivity disorder (ADHD): an update on the controversies |
| Q24246488 | Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children |
| Q24244291 | Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents |
| Q51938163 | Foreword -- ADHD in the scientific and political context. |
| Q35986924 | Geographic analysis of the variation in the incidence of ADHD in a country with free access to healthcare: a Danish cohort study |
| Q36649094 | Geographic variation and disparity in stimulant treatment of adults and children in the United States in 2008 |
| Q50307492 | Girls with social and/or attention deficits: a descriptive study of 100 clinic attenders |
| Q51939026 | Healthcare use by children with attention deficit/hyperactivity disorder with and without psychiatric comorbidities. |
| Q37301222 | Improving psychostimulant adherence in children with ADHD. |
| Q34531941 | Integrative neuroscience approach to predict ADHD stimulant response |
| Q40826720 | Is ADHD Really Increasing in Youth? |
| Q34400595 | Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands |
| Q40835217 | Long-term effects of chronic oral Ritalin administration on cognitive and neural development in adolescent wistar kyoto rats. |
| Q37015206 | Longitudinal mental health service and medication use for ADHD among Puerto Rican youth in two contexts |
| Q93487269 | L’utilisation des stimulants dans le traitement du trouble de déficit de l’attention avec hyperactivité |
| Q36855978 | Medication prescribing practices in a child and adolescent psychiatry outpatient clinic |
| Q48115819 | Methylphenidate administration to juvenile rats alters brain areas involved in cognition, motivated behaviors, appetite, and stress. |
| Q28344200 | Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder |
| Q43747165 | Nationwide rate of attention-deficit hyperactivity disorder diagnosis and pharmacotherapy in Korea in 2008-2011. |
| Q31070157 | Naturalistic Pharmacotherapy Compliance among Pediatric Patients with Attention Deficit/Hyperactivity Disorder: a Study Based on Three-Year Nationwide Data |
| Q34549712 | Overdiagnosis of mental disorders in children and adolescents (in developed countries). |
| Q36038696 | Parental attitudes toward the prescription of psychotropic medications for their children |
| Q38443849 | Partnerships for Quality project: closing the gap in care of children with ADHD. |
| Q36930852 | Pediatric psychopharmacology: Too much and too little |
| Q36930848 | Pediatric psychopharmacology: too much or too little? |
| Q47636039 | Perceptions of ADHD Among Diagnosed Children and Their Parents: A Systematic Review Using the Common-Sense Model of Illness Representations |
| Q35784050 | Pharmacological management of attention-deficit hyperactivity disorder |
| Q36730671 | Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches. |
| Q30558510 | Prediction of 7-year psychopathology from mother-infant joint attention behaviours: a nested case-control study |
| Q39111481 | Preschool ADHD Diagnosis and Stimulant Use Before and After the 2011 AAP Practice Guideline |
| Q98472594 | Prescribing Practices in Child and Adolescent Psychiatry: Change Over Time 1993-2000 |
| Q53674622 | Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. |
| Q51938172 | Primary care clinicians' use of standardized psychiatric diagnoses. |
| Q46004222 | Protopathic stimulant use among children with symptoms of ADHD. |
| Q37273951 | Quantitative electroencephalography and attention-deficit/hyperactivity disorder: implications for clinical practice |
| Q34998759 | Racial/ethnic differences in the use of psychotropic medication in high-risk children and adolescents |
| Q36485658 | Research in child and adolescent psychopharmacology: recent accomplishments and new challenges |
| Q22251206 | Review of Pediatric Attention Deficit/Hyperactivity Disorder for the General Psychiatrist |
| Q60621448 | Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment |
| Q34337599 | Social and economic determinants of disparities in professional help-seeking for child mental health problems: evidence from a national sample. |
| Q34552192 | Stimulant and atypical antipsychotic medications for children placed in foster homes |
| Q38113515 | Stimulant medication and substance use outcomes: a meta-analysis. |
| Q21203515 | The NARCONON drug education curriculum for high school students: a non-randomized, controlled prevention trial |
| Q33757292 | The Prevalence of ADHD in a Population-Based Sample |
| Q83431392 | The evidence-based pharmacological treatment of paediatric ADHD |
| Q49167944 | The use of health care services and psychotropic medication in a community sample of 9-year-old schoolchildren with ADHD. |
| Q82385416 | The use of stimulant medication in the treatment of attention deficit hyperactivity disorder |
| Q36110054 | The validity of the DSM-IV subtypes of attention-deficit/hyperactivity disorder |
| Q37777094 | Treatment of Preschoolers with Attention-Deficit/Hyperactivity Disorder |
| Q58468264 | Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate |
| Q36509415 | Understanding the agreements and controversies surrounding childhood psychopharmacology |
| Q38192711 | Uses and misuses of treatments for ADHD. The second Birgit Olsson lecture |
| Q34628186 | Who first suggests the diagnosis of attention-deficit/hyperactivity disorder? |
Search more.